Back to Search
Start Over
[Development of tyrosine kinase inhibitors for hematologic neoplasms. FLT3 and JAK2 as therapeutic targets].
- Source :
-
Pharmazie in unserer Zeit [Pharm Unserer Zeit] 2008; Vol. 37 (5), pp. 394-403. - Publication Year :
- 2008
- Subjects :
- Animals
Hematologic Neoplasms enzymology
Hematologic Neoplasms genetics
Humans
Hematologic Neoplasms drug therapy
Janus Kinase 2 drug effects
Protein Kinase Inhibitors pharmacology
Protein Kinase Inhibitors therapeutic use
Protein-Tyrosine Kinases antagonists & inhibitors
fms-Like Tyrosine Kinase 3 drug effects
Subjects
Details
- Language :
- German
- ISSN :
- 0048-3664
- Volume :
- 37
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Pharmazie in unserer Zeit
- Publication Type :
- Academic Journal
- Accession number :
- 18729264
- Full Text :
- https://doi.org/10.1002/pauz.200800280